Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Prosperini

Showing results (131-140 of 182) with videos related to

Pageof 19
Sort By:
Journal of Neurology|February 20, 2021
Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)Veronica Villani, Elena Anghileri, Luca Prosperini, et al.
Multiple Sclerosis and Related Disorders|July 28, 2021
Italian translation and psychometric validation of the ABILHAND-26 and its correlation with upper limb objective and subjective measures in multiple sclerosis subjectsErica Grange, Davide Marengo, Rachele Di Giovanni, et al.
European Journal of Neurology|September 10, 2022
Correlation between patient-reported manual ability and three objective measures of upper limb function in people with multiple sclerosisClaudio Solaro, Rachele Di Giovanni, Erica Grange, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2020
Italian translation and psychometric validation of the Manual Ability Measure-36 (MAM-36) and its correlation with an objective measure of upper limb function in patients with multiple sclerosisClaudio Solaro, Rachele Di Giovanni, Erica Grange, et al.
Neurology International|August 27, 2025
Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple SclerosisElisa Petruccioli, Luca Prosperini, Serena Ruggieri, et al.
Plos One|July 31, 2019
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray)Alessandro Enrico Grimaldi, Laura De Giglio, Shalom Haggiag, et al.
Neuroepidemiology|March 5, 2018
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture AnalysisAlessio Farcomeni, Antonio Cortese, Eleonora Sgarlata, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 3, 2020
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World StudyLuca Prosperini, Chiara Rosa Mancinelli, Claudio Marcello Solaro, et al.
European Neurology|February 1, 2014
From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter studyLuca Prosperini, Chiara Rosa Mancinelli, Carlo Pozzilli, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 22, 2024
Cortical plasticity in AQP4-positive NMOSD: a transcranial magnetic stimulation studyAlessandro Cruciani, Fioravante Capone, Shalom Haggiag, et al.
Pageof 19

Showing results (131-140 of 182) with videos related to

Sort By:
Pageof 19
Journal of Neurology|February 20, 2021
Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)Veronica Villani, Elena Anghileri, Luca Prosperini, et al.
Multiple Sclerosis and Related Disorders|July 28, 2021
Italian translation and psychometric validation of the ABILHAND-26 and its correlation with upper limb objective and subjective measures in multiple sclerosis subjectsErica Grange, Davide Marengo, Rachele Di Giovanni, et al.
European Journal of Neurology|September 10, 2022
Correlation between patient-reported manual ability and three objective measures of upper limb function in people with multiple sclerosisClaudio Solaro, Rachele Di Giovanni, Erica Grange, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 25, 2020
Italian translation and psychometric validation of the Manual Ability Measure-36 (MAM-36) and its correlation with an objective measure of upper limb function in patients with multiple sclerosisClaudio Solaro, Rachele Di Giovanni, Erica Grange, et al.
Neurology International|August 27, 2025
Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple SclerosisElisa Petruccioli, Luca Prosperini, Serena Ruggieri, et al.
Plos One|July 31, 2019
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray)Alessandro Enrico Grimaldi, Laura De Giglio, Shalom Haggiag, et al.
Neuroepidemiology|March 5, 2018
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture AnalysisAlessio Farcomeni, Antonio Cortese, Eleonora Sgarlata, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 3, 2020
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World StudyLuca Prosperini, Chiara Rosa Mancinelli, Claudio Marcello Solaro, et al.
European Neurology|February 1, 2014
From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter studyLuca Prosperini, Chiara Rosa Mancinelli, Carlo Pozzilli, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 22, 2024
Cortical plasticity in AQP4-positive NMOSD: a transcranial magnetic stimulation studyAlessandro Cruciani, Fioravante Capone, Shalom Haggiag, et al.
Pageof 19